Estrogens, the menopause, and osteoporosis

Bone

Volumn 19, Issue 5 SUPPL., 1996, Pages

  Kanis, John A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Estrogens; Hip fracture; Hormone replacement therapy; Menopause; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ESTROGEN; GESTAGEN; NORETHISTERONE ACETATE; VITAMIN D;

ADULT; AGED; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; GONAD FUNCTION; HIP FRACTURE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MALE; MENOPAUSE; OSTEOPOROSIS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS;

EID: 0029857835     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00257-8     Document Type: Conference Paper

References (26)

1. Anonymous. Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646-650; 1993.
2. Christiansen, C., Nilas, L., Riis, B., Rodbro, P., and Deftos, L. Uncoupling of bone formation and resorption by combined oestrogen and progestogen therapy in postmenopausal osteoporosis. Lancet 2:800-801; 1985.
3. Consensus Development Conference: Who are candidates for preventative and therapeutic therapy for osteoporosis? World Congress of Osteoporosis, Amsterdam; 1996.
4. Elffors, L., Allander, E., Kanis, J. A., et al. The variable incidence of hip fractures in Southern Europe. The MEDOS study. Osteopor Int 4:253-263; 1994.
5. Eriksen, E. F. Normal and pathological remodelling of human trabecular bone: three dimensional reconstruction of the remodelling sequence in normals and in metabolic bone disease. Endocrine Rev 7:379-408; 1986.
6. Garnett, T., Savvas, M., and Studd, J. W. W. Reversal of bone loss with percutaneous oestrogens. Drife, J. O. and Studd, J. W. W., Eds. HRT and osteoporosis. London: Springer Verlag; 1990; 295-314.
7. Grey, A., Cundy, T., Evans, M., and Reid, I. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late postmenopausal women. Clin Endocrinol 44:293-296; 1996.
8. Johnell, O., Gullberg, B., Allander, A., and Kanis, J. A. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteopor Int 2:298-302; 1992.
9. Johnell, O., Gullberg, B., Kanis, J. A., et al. Risk factors for hip fracture in European women. The MEDOS study. J Bone Miner Res 10:1802-1815; 1995.
10. Johnell, O., Stenbeck, M., Rosen, M., Gullberg, B., and Kanis, J. A. Therapeutic strategies in the prevention of the hip fractures with drugs affecting bone metabolism. Bone 14(suppl 1):S85-87; 1993.
11. Kanis, J. A. Treatment of osteoporotic fracture. Lancet 1:27-33; 1984.
12. Kanis, J. A. The restoration of skeletal mass: A theoretic overview. Am J Med 91:29-36; 1991.
13. Kanis, J. A. and Pitt, F. A. Epidemiology of osteoporosis. Bone 13(suppl):S7-15; 1992.
14. Kanis, J. A. Treatment of osteoporosis in elderly women. Am J Med 98(suppl 2A):60-66; 1995.
15. Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., and Khaltaev, N. The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141; 1994.
16. Kanis, J. A. and Stevenson, J. C. Apparent offset of action of estrogens. New Engl J Med 330:715; 1994.
17. Law, M. R., Wald, N. J., and Meade, T. W. Strategies for prevention of osteoporosis and hip fracture. Br Med J 303:453-459; 1991.
18. Lindsay, R. The pharmacology of estrogens. Prog Basic Clin Pharmacol 4:55-72; 1990.
19. Lindsay, R., Hart, D. M., and Clark, D. M. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:754-763; 1984.
20. Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., et al., Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1-9; 1992.
21. Melton, L. J., O'Fallon, W. M., and Riggs, B. L. Secular trends in the incidence of hip fractures. Calcif Tissue Int 41:57-64; 1987.
22. Parfitt, A. M. Age-related structural changes in trabecular and cortical bone: Cellular mechanisms and biochemical consequences. Calcif Tissue Int 36:122-128; 1984.
23. Rozenbaum, H. and Birkhäuser, M. H. Consensus propositions. Rozenbaum, H., and Birkhäuser, M. H., Eds. Menopause, European Consensus Development Conference, Montreux, Switzerland. Paris: ESKA; 1996; 293-303.
24. Steiniche, T., Hasling, C., Charles, P., et al. A randomised study on the effects of estrogen, gestagen or high oral dose calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10:313-320; 1989.
25. Stevenson, J. C., Kanis, J. A., and Christiansen, C. Bone density measurement. Lancet 339:370-371; 1992.
26. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: WHO; 1994.